Citadel Advisors
MJN

Citadel Advisors’s Mead Johnson Nutrition Company MJN Stock Holding History

Citadel Advisors’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-21,100
Closed -$1.88M – 8526
2017
Q1 		$1.88M Sell
21,100
-2,400
-10% -$197K ﹤0.01% 3147
2016
Q4 		$1.66M Sell
23,500
-2,100
-8% -$157K ﹤0.01% 3176
2016
Q3 		$2.02M Sell
25,600
-19,100
-43% -$1.63M ﹤0.01% 2959
2016
Q2 		$4.06M Sell
44,700
-62,800
-58% -$5.32M ﹤0.01% 1999
2016
Q1 		$9.13M Buy
107,500
+33,000
+44% +$2.45M 0.01% 1266
2015
Q4 		$5.88M Buy
74,500
+48,600
+188% +$3.83M 0.01% 1667
2015
Q3 		$1.82M Sell
25,900
-15,000
-37% -$1.23M ﹤0.01% 3064
2015
Q2 		$3.69M Sell
40,900
-300
-0.7% -$28.9K ﹤0.01% 2358
2015
Q1 		$4.14M Buy
41,200
+14,300
+53% +$1.44M ﹤0.01% 2229
2014
Q4 		$2.71M Sell
26,900
-15,000
-36% -$1.5M ﹤0.01% 2588
2014
Q3 		$4.03M Buy
41,900
+23,500
+128% +$2.23M ﹤0.01% 2185
2014
Q2 		$1.71M Sell
18,400
-200
-1% -$17.5K ﹤0.01% 2883
2014
Q1 		$1.55M Sell
18,600
-17,000
-48% -$1.38M ﹤0.01% 2908
2013
Q4 		$2.98M Sell
35,600
-22,100
-38% -$1.8M ﹤0.01% 2145
2013
Q3 		$4.29M Sell
57,700
-29,900
-34% -$2.24M 0.01% 1690
2013
Q2 		$6.94M Buy
+87,600
New +$7.02M 0.01% 1298

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Citadel Advisors's MJN Position: Q2 2017 in Review

Citadel Advisors sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 199,060 shares — an estimated $17.7M sold.

Citadel Advisors first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $202M in Q2 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Citadel Advisors reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 199,060 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $17.7M.
  • Citadel Advisors first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Citadel Advisors's Mead Johnson Nutrition Company position peaked at $202M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.